Skip to main content
A-LevelBiologyInherited change9700/42 · May/June 2024 · Q510 Marks

The gene BRCA1 is expressed in breast tissue and in several other tissues of the body. BRCA1 codes for a tumour suppressor protein. This protein is involved in either repairing damaged DNA, or in triggering the death of a cell if DNA cannot be repaired. Some mutations in BRCA1 are associated with an increased risk of developing breast cancer.

  1. (a)State one reason why a doctor would recommend that a person has genetic testing for a mutation in the gene BRCA1 and explain why this mutation would put the person at a greater risk of breast cancer.[4]
  2. (b)DNA sequencing is one method used to test for mutations in BRCA1. Before DNA sequencing occurs, the DNA sample goes through the polymerase chain reaction (PCR). Suggest why PCR is used for testing for mutations in BRCA1.[2]
  3. (c)Genetic screening shows that in the UK: • 1 in 400 females have a mutated allele of BRCA1 • 70% of females with a mutated allele of BRCA1 will develop breast cancer by the time they are 80 years old. In 2022, the population of females in the UK was 3.5 × 10^7. Calculate the number of females in the UK population in 2022 who it is estimated will develop breast cancer by the age of 80 years old. Give your answer in standard form. Show your working. number of females =[2]
  4. (d)One advantage of genetic screening is to determine which drugs should be selected to treat cancer. A study was carried out on women with breast cancer who had been treated with a DNA-damaging drug that kills tumour cells. The women had all been tested for BRCA1 mutations. One group had a BRCA1 mutation and the other group did not have a BRCA1 mutation. The researchers used data to assess the probability of survival for the women in each group of the study after treatment with the drug. [Figure 5.1] shows the probability of survival for a time period of up to 180 months. The researchers suggested the hypothesis that the DNA-damaging drug is more effective in women with a BRCA1 mutation. Discuss whether the results in Fig. 5.1 support the hypothesis suggested by the researchers.[2]

This question uses a diagram from the original paper, which isn't shown here. Open the full paper from the past papers archive to see it.

Mark scheme

Marking points from the official mark scheme (May/June 2024). The mark or mark type is shown in brackets.

  1. [4] (a) 1 family history of, breast / ovarian, cancer ;
  2. [4] (a) plus any three from:
  3. [4] (a) 2 (mutation causes) change of primary structure (of tumour suppressor protein) ;
  4. [4] (a) 3 changes, folding / bonding / 3D shape / tertiary structure (of tumour suppressor protein) ;
  5. [4] (a) 4 non-functional (tumour suppressor) protein formed ;
  6. [4] (a) 5 DNA is not repaired / cells with damaged DNA do not die ;
  7. [4] (a) 6 (so) increases number of mutations / mutations accumulate ;
  8. [4] (a) 7 (some mutations) cause uncontrollable, cell division / mitosis (of breast cells) ;
  9. [2] (b) 1 only small amount of DNA available ; A gene
  10. [2] (b) 2 amplify, DNA / (BRCA1) gene ;
  11. [2] (c) 6.1 x 10^4 ;;
  12. [2] (c) A 6.125 × 10^4 for two marks
  13. [2] (c) allow one mark for 61 250 or 3.5 × 10^7 / 400 = 8.75 × 10^4 or 87 500
  14. [2] (d) any two from:
  15. [2] (d) supports:
  16. [2] (d) 1 (women with BCRA1) have a higher probability of survival ; ora
  17. [2] (d) 2 (for women with BRCA1) the probability of survival decreases less or there is a smaller rate of decrease of probability of survival or bigger difference between the two groups over time for the probability of survival ; ora
  18. [2] (d) 3 data quote to show differences between the survival of the two groups at a particular time ;
  19. [2] (d) 4 study carried out for, a long time / 15 years ;
  20. [2] (d) does not support:
  21. [2] (d) 5 no statistical test carried out / ref. to sample size ;
  22. [2] (d) probability of survival table at 30, 60, 90, 120, 150, 180 months for both groups for mp3

Write your answer and get it marked

On Oracle Prep you can write or photograph your own answer and have it marked by AI against this mark scheme, with feedback on what you missed.

Sign up free →

About this question

Topic
Inherited change, A-Level Biology (syllabus 9700). Structured question, 10 marks.
Source
A-Level Biology, May/June 2024 Paper 4 Variant 2, question 5.

Questions and mark schemes are from past examination papers and remain the copyright of the exam board. How Oracle Prep builds its content

Related Biology questions

© 2026 Oracle Prep